Cited by

• Factors Associated With Levels of Public Engagement in Protective Behaviors During the Early COVID-19 Pandemic: Causal-Comparative Study Based on the Health Belief Model.

  Tang CC, Chen H, Tsai SY, Wu WW. Tang CC, et al. JMIR Hum Factors. 2023 Dec 19;10:e49687. doi: 10.2196/49687. JMIR Hum Factors. 2023. PMID: 38113083 Free PMC article.
• SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infection.

  Khateeb D, Gabrieli T, Sofer B, Hattar A, Cordela S, Chaouat A, Spivak I, Lejbkowicz I, Almog R, Mandelboim M, Bar-On Y. Khateeb D, et al. PLoS Pathog. 2022 Jan 12;18(1):e1010242. doi: 10.1371/journal.ppat.1010242. eCollection 2022 Jan. PLoS Pathog. 2022. PMID: 35020754 Free PMC article. Clinical Trial.
• Continuously-deformable and stiffness-tunable soft manipulator achieving unmanned COVID-19 pandemic sampling.

  Zhang J, Liu L, Zhu M, Li D, Lu J. Zhang J, et al. Heliyon. 2023 Feb;9(2):e13731. doi: 10.1016/j.heliyon.2023.e13731. Epub 2023 Feb 14. Heliyon. 2023. PMID: 36816282 Free PMC article.
• Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms.

  Aileni M, Rohela GK, Jogam P, Soujanya S, Zhang B. Aileni M, et al. Cells. 2022 Mar 31;11(7):1182. doi: 10.3390/cells11071182. Cells. 2022. PMID: 35406746 Free PMC article. Review.
• SARS-CoV-2 Genetic Variability and Non-Specific Immunity Associated with the Use of Different BCG Strains-A Molecular and Clinical Approach.

  Kulus J, Kulus M, Stefańska K, Sobolewski J, Piotrowska-Kempisty H, Mozdziak P, Kempisty B. Kulus J, et al. Vaccines (Basel). 2021 Jun 10;9(6):639. doi: 10.3390/vaccines9060639. Vaccines (Basel). 2021. PMID: 34200951 Free PMC article. Review.